Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Tvardi Therapeutics, Inc. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
SP
Slate Path Capital LP
|
704.1K | 5.56% | Unchanged | 2025 | 0.0% | |
|
Shares held by quarter
Peak holding704.1K (Q2'25)
Change over 8 quarters+704.1K
Share of the company5.560%
|
||||||
|
B
BlackRock, Inc.
|
95.5K | 0.75% | −292.6K (−75.4%) | ≤2021 | 0.0% | |
|
Shares held by quarter
Peak holding742.5K (Q3'24)
Change over 8 quarters−647.0K
Share of the company0.750%
|
||||||
28 more super investors behind a free account
See every manager holding Tvardi Therapeutics, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$491K | 258.4K | 2.04% | 0.00% | June 30, 2026 |
|
FS
Fidelity Salem Street Trust
|
$186K | 59.0K | 0.47% | 0.00% | April 30, 2026 |
23 more funds behind a free account
See every fund holding Tvardi Therapeutics, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
WS
Wirk Shaheen
Insider
|
439.2K | 3.47% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company3.470%
|
||||||
|
TS
Tweardy Samuel David
Insider
|
315.7K | 2.49% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company2.490%
|
||||||
5 more holders behind a free account
See every insider and 5%+ holder of Tvardi Therapeutics, Inc..
Sign up freeLoading...